Mono Vaccine Market Size, Share, Trends, Growth Outlook

Mono Vaccine Market is estimated to increase at a growth rate of 5.7% CAGR over the forecast period from 2024 to 2030.

The global Mono Vaccine Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Meningococcal Vaccine, Japanese Encephalitis Vaccine, Hepatitis Vaccine, Yellow Fever Vaccine, Others).

An Introduction to Mono Vaccine Market in 2024

The mono vaccine market in 2024 is witnessing significant growth driven by the global efforts to combat infectious diseases caused by the Epstein-Barr virus (EBV), particularly infectious mononucleosis and certain types of cancers associated with EBV infection. Mono vaccines aim to stimulate the immune system to produce antibodies against EBV, thereby reducing the risk of infection and related complications. With advancements in vaccine development technologies, including recombinant DNA techniques and viral vector platforms, mono vaccines offer promising prospects for disease prevention and public health intervention. Market players are investing in research and development to accelerate vaccine candidates through clinical trials and regulatory approval processes, thus addressing unmet medical needs and contributing to the control of EBV-related diseases.

Mono Vaccine Market Competitive Landscape

The global Mono Vaccine Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Mono Vaccine Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Mono Vaccine Industry include- AstraZeneca Plc, Aurobindo Pharma Ltd, Bavarian Nordic AS, China National Pharmaceutical Group Corp, Dynavax Technologies Corp, GlaxoSmithKline Plc, Johnson and Johnson, Merck and Co. Inc, Moderna Inc, Pfizer Inc, Sanofi S.A., Serum Institute of India Pvt. Ltd, Shenzhen Kangtai Biological Products Co. Ltd, Valneva SE, VBI Vaccines Inc.

Mono Vaccine Market Trend: Rise in Demand for Single-Dose Vaccines

A significant trend in the mono vaccine market is the increasing demand for single-dose vaccines. Single-dose vaccines, also known as monovalent vaccines, offer several advantages over traditional multi-dose vaccines, including simplified vaccination schedules, improved patient compliance, and reduced healthcare costs. With the global focus on enhancing vaccination coverage and achieving herd immunity against infectious diseases, there is a growing preference for vaccines that require fewer doses to complete the immunization regimen. Mono vaccines, designed to protect against a single pathogen or disease, cater to this demand by offering convenient and efficient vaccination solutions. Additionally, the emergence of new infectious diseases and the need for rapid vaccine development in response to outbreaks further drive the market for mono vaccines, as they enable expedited vaccine production and deployment in emergency situations.

Mono Vaccine Market Driver: Efforts to Combat Emerging Infectious Diseases

The primary driver of the mono vaccine market is the concerted efforts to combat emerging infectious diseases. With the ongoing threat of pandemics and epidemics caused by novel pathogens, such as coronaviruses, influenza viruses, and other emerging infectious agents, there is an urgent need for effective vaccines to prevent disease transmission and control outbreaks. Mono vaccines play a crucial role in the vaccination strategies adopted by public health authorities and governments worldwide to mitigate the impact of infectious diseases on population health and socioeconomic stability. By targeting specific pathogens or antigens, mono vaccines enable precise immune responses tailored to the antigenic characteristics of the pathogen, thereby enhancing vaccine efficacy and reducing the risk of adverse reactions. Furthermore, advancements in vaccine technology, such as recombinant DNA technology, viral vector platforms, and protein subunit vaccines, facilitate the development of safe and effective mono vaccines against emerging infectious threats, driving innovation and investment in the mono vaccine market.

Mono Vaccine Market Opportunity: Expansion into Veterinary Vaccines

An opportunity for market expansion lies in the development and commercialization of mono vaccines for veterinary applications. While mono vaccines have primarily been focused on human infectious diseases, there is growing recognition of the importance of vaccination in animal health and welfare. Veterinary vaccines play a critical role in preventing and controlling infectious diseases in livestock, poultry, aquaculture, and companion animals, contributing to food safety, animal production efficiency, and public health. By leveraging their expertise in vaccine development and manufacturing, companies in the mono vaccine market can diversify their product portfolios to include veterinary vaccines targeting pathogens of veterinary significance. These vaccines address unmet needs in animal health management, such as the prevention of zoonotic diseases, emerging infectious diseases in livestock, and infectious diseases with significant economic impact on the agriculture sector. Moreover, collaboration with veterinary medicine professionals, research institutions, and regulatory agencies facilitates the registration, distribution, and uptake of mono vaccines in the veterinary market, creating new revenue streams and business opportunities for vaccine manufacturers.

Mono Vaccine Market Share Analysis: Meningococcal Vaccine is the fastest growing market segment over the forecast period to 2030

Meningococcal vaccine emerges as the fastest-growing segment within the mono vaccine market. This growth is propelled by the increasing global concern over meningococcal disease, which can lead to severe meningitis and septicemia, particularly among infants, adolescents, and young adults. Meningococcal vaccines are specifically designed to protect against the Neisseria meningitidis bacterium, which is a leading cause of meningococcal infections worldwide. With rising awareness of the potentially devastating consequences of meningococcal disease, there has been a growing emphasis on vaccination campaigns aimed at high-risk populations, such as individuals living in crowded settings like college dormitories, military barracks, and refugee camps. Furthermore, the introduction of newer-generation meningococcal vaccines, including conjugate vaccines offering broader protection against multiple serogroups, has contributed to the expansion of the meningococcal vaccine market. As healthcare authorities and policymakers prioritize meningococcal vaccination programs to prevent outbreaks and reduce disease burden, the demand for meningococcal vaccines is expected to continue rising. This growth underscores the critical role of meningococcal vaccines in safeguarding public health and preventing potentially life-threatening meningococcal infections, highlighting the importance of vaccination as a cornerstone of disease prevention strategies worldwide.

Mono Vaccine Market Segmentation

By Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Hepatitis Vaccine
Yellow Fever Vaccine
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Mono Vaccine Companies

AstraZeneca Plc
Aurobindo Pharma Ltd
Bavarian Nordic AS
China National Pharmaceutical Group Corp
Dynavax Technologies Corp
GlaxoSmithKline Plc
Johnson and Johnson
Merck and Co. Inc
Moderna Inc
Pfizer Inc
Sanofi S.A.
Serum Institute of India Pvt. Ltd
Shenzhen Kangtai Biological Products Co. Ltd
Valneva SE
VBI Vaccines Inc
* List not Exhaustive

Reasons to Buy the Mono Vaccine Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Mono Vaccine Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Mono Vaccine Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Mono Vaccine Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Mono Vaccine Market Size Outlook, $ Million, 2021 to 2030
3.2 Mono Vaccine Market Outlook by Type, $ Million, 2021 to 2030
3.3 Mono Vaccine Market Outlook by Product, $ Million, 2021 to 2030
3.4 Mono Vaccine Market Outlook by Application, $ Million, 2021 to 2030
3.5 Mono Vaccine Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Mono Vaccine Industry
4.2 Key Market Trends in Mono Vaccine Industry
4.3 Potential Opportunities in Mono Vaccine Industry
4.4 Key Challenges in Mono Vaccine Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Mono Vaccine Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Mono Vaccine Market Outlook by Segments
7.1 Mono Vaccine Market Outlook by Segments, $ Million, 2021- 2030
By Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Hepatitis Vaccine
Yellow Fever Vaccine
Others
8 North America Mono Vaccine Market Analysis and Outlook To 2030
8.1 Introduction to North America Mono Vaccine Markets in 2024
8.2 North America Mono Vaccine Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Mono Vaccine Market size Outlook by Segments, 2021-2030
By Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Hepatitis Vaccine
Yellow Fever Vaccine
Others
9 Europe Mono Vaccine Market Analysis and Outlook To 2030
9.1 Introduction to Europe Mono Vaccine Markets in 2024
9.2 Europe Mono Vaccine Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Mono Vaccine Market Size Outlook by Segments, 2021-2030
By Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Hepatitis Vaccine
Yellow Fever Vaccine
Others
10 Asia Pacific Mono Vaccine Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Mono Vaccine Markets in 2024
10.2 Asia Pacific Mono Vaccine Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Mono Vaccine Market size Outlook by Segments, 2021-2030
By Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Hepatitis Vaccine
Yellow Fever Vaccine
Others
11 South America Mono Vaccine Market Analysis and Outlook To 2030
11.1 Introduction to South America Mono Vaccine Markets in 2024
11.2 South America Mono Vaccine Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Mono Vaccine Market size Outlook by Segments, 2021-2030
By Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Hepatitis Vaccine
Yellow Fever Vaccine
Others
12 Middle East and Africa Mono Vaccine Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Mono Vaccine Markets in 2024
12.2 Middle East and Africa Mono Vaccine Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Mono Vaccine Market size Outlook by Segments, 2021-2030
By Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Hepatitis Vaccine
Yellow Fever Vaccine
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AstraZeneca Plc
Aurobindo Pharma Ltd
Bavarian Nordic AS
China National Pharmaceutical Group Corp
Dynavax Technologies Corp
GlaxoSmithKline Plc
Johnson and Johnson
Merck and Co. Inc
Moderna Inc
Pfizer Inc
Sanofi S.A.
Serum Institute of India Pvt. Ltd
Shenzhen Kangtai Biological Products Co. Ltd
Valneva SE
VBI Vaccines Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Hepatitis Vaccine
Yellow Fever Vaccine
Others